市場調査レポート
商品コード
1123242
感染症対策の世界市場:予測(2022年~2028年)Global Infection Control Market Research and Forecast 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
感染症対策の世界市場:予測(2022年~2028年) |
出版日: 2022年08月01日
発行: Orion Market Research
ページ情報: 英文 100 Pages
納期: 2~3営業日
|
世界の感染症対策の市場規模は、予測期間(2022年~2028年)中に6.8%のCAGRで成長すると予想されています。慢性疾患の発生率の上昇、外科手術の件数の増加、効率的な予防策についての認識を促すための政府によるガイドラインの公開の増加は、感染症対策市場の成長を後押ししています。
当レポートでは、世界の感染症対策市場について調査分析し、市場概要、競合情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。
カテゴリー:医薬品 1. レポート概要
Global Infection Control Market Size, Share & Trends Analysis Report by Equipment (Disinfectors and Sterilization Equipment), By End-User (Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, and Others), By Services (ETO Sterilization Services, Gamma Sterilization Services, E-Beam Sterilization Services, and Others), and Forecast Period 2021-2027
The global infection control market is anticipated to grow at a CAGR of nearly 6.8% during the forecast period. Infection control prevents the spread of infections in the healthcare sector, primarily in hospitals and clinics. Infection control supports in reducing the occurrence of infectious diseases which are usually caused by bacteria or viruses present in the environment. The key factors that are motivating the growth of the infection control market include the rising incidences of chronic diseases and the rising number of surgical procedures. In addition, the increasing number of surgical procedures, the rising issue of guidelines by the government to promote awareness about efficient prevention measures globally, and the high incidence of hospital-acquired infections (HAIs) are also driving the growth of the market. For instance, in March 2020, the World Health Organization (WHO) has issued guidelines for the prevention and control of COVID-19 pandemic and respiratory diseases in healthcare. The guidelines issued for the precautions such as hand hygiene, usage of personal protective equipment, to guidelines for disinfection, and sterilization.
Furthermore, the increasing demand for sterilization method in pharmaceutical companies, and the technological advancement in sterilization equipment are the factors that are propelling the growth of the market. Stringent regulation for sterilization manufacturer in terms of product approval may restrict the growth of this market. Besides, rising concerns regarding the safety and performance of reprocessed devices are also hindering the market growth. However, advances in sterilization technology and increasing use of E-beam sterilization have brought new opportunity for this market.
Segmental Outlook
The global infection control market is segmented based on equipment, end-user, and services. Based on the equipment, the market is segmented into disinfectors and sterilization equipment. Based on the end-user, the market is segmented into hospitals and clinics, pharmaceutical companies, medical device companies, and others. Based on the services, the market is segmented into ETO sterilization services, gamma sterilization services, e-beam sterilization services, and others.
Global Infection Control Market Share by End-User, 2020 (%)
Global Infection Control Market Share by End-User
Hospitals and Clinics holds Significant share in the Market During the Forecast Period
In 2020, hospitals and clinics held the largest share in the market owing to the rising prevalence of the HAIs and emerging focus on cleaning and disinfection solutions across hospitals and clinics to prevent the spread of the infection. In American hospitals alone, the Centers for Disease Control (CDC) estimates that healthcare-acquired infections (HAIs) account for an estimated 1.7 million infections and 99,000 associated deaths annually. In addition, the rising number of surgeries performed in hospitals and the rising number of multi-specialty hospitals is also contributing to the potential share of infection control techniques in hospitals.
Regional Outlook
The market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America region represents considerably the largest market for infection control in terms of revenue generation. It is growing due to strict regulation on infection prevention in hospitals and the significant prevalence of healthcare-acquired infections (HAIs) in the region. In addition, the presence of major players such as Ecolab Inc, STERIS Corp., and others are further contributing to the launch of new infection control products in the region. Along with this, Germany has a significant share in the Europe infection control market owing to the rising number of surgeries performed in the country and significant growth in the medical device industry in the country.
Global Infection Control Market Growth, by Region 2021-2027
Global Infection Control Market Growth, by Region
Asia-Pacific is expected to have considerable shares in the global Infection Control market
Asia-Pacific is anticipated to hold considerable market share in the market owing to the presence of pharmaceutical outsourcing organizations, rising healthcare expenditure, and well-developed healthcare standards and infrastructure. Increasing pharmaceutical and medical device industries, increasing incidence of nosocomial infections, and improving healthcare infrastructure in the region are the important factors that are driving the infection control market in the Asia-pacific region. In addition, the COVID-19 pandemic has further encouraged the adoption of infection prevention and control products across healthcare infrastructure.
Market Players Outlook
Key players operating in the market include 3M Co., ASP Global manufacturing GmbH, Belimed AG, Ecolab, Inc., Getinge AB, and Steris Corp. The market players are focusing on various strategic initiatives such as mergers & acquisitions, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2020, Getinge declared the acquisition of Quadralene, a manufacturer of, and expert in, decontamination products including detergents and disinfectants for the healthcare and dental sector. Quadralene will be a part of Infection Control in the business area of Surgical Workflows of Getinge.
The Report Covers
Market value data analysis of 2020 and forecast to 2027.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global infection control market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.